HealthDay News — The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over two seasons, according to a study published online Sept. 3 in JAMA Network Open.

RSV, or respiratory syncytial virus, is a common illness that can cause serious breathing problems in infants, young children, and older adults. Doctors say cas

A large, real-world randomized trial in Denmark found that the RSVpreF vaccine reduced RSV-related hospitalizations in adults aged 60 and over by over 80%. The vaccine also showed protection against broader respiratory illness with a favorable safety profile.

Mandy Moore recalls when her sons were both diagnosed with RSV in 2023, and how the scary health ordeal made her feel in an exclusive interview with PEOPLE. The actress is a mom to three children — sons August 'Gus' Harrison and Oscar 'Ozzie' Bennett,

GSK announced today that Arexvy (respiratory syncytial virus vaccine – recombinant, AS01E adjuvanted) will be offered through select provincially funded

HealthDay News — The respiratory syncytial virus (RSV) vaccine reduces RSV-associated hospitalization among older adults over two seasons, according to a study published online September 3 in JAMA Network Open.

Being born in winter, small for gestational age, and prematurely increase the odds of severe outcomes of respiratory syncytial virus infection.

Among infants admitted to the ICU with RSV infection, underlying comorbidities were present in only 41.3% of cases.